New Key Statistics Module, Z-Score and F-Score
NAS:DCPH Key Ratios
Market Cap $ M | 1,227.35 |
Enterprise Value $ M | 917.12 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 3.48 |
Price/Sales | 8.11 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 163.00 |
EPS (TTM) $ | -2.29 |
Beneish M-Score | -1.82 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 6.90 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -4.39 |
EV-to-EBITDA | -4.44 |
PEG | -- |
Shares Outstanding M | 80.80 |
Net Margin (%) | -119.34 |
Operating Margin % | -129.14 |
Pre-tax Margin (%) | -119.07 |
Quick Ratio | 3.59 |
Current Ratio | 3.80 |
ROA % (ttm) | -39.24 |
ROE % (ttm) | -50.80 |
ROIC % (ttm) | -187.89 |
Dividend Yield % | -- |
Altman Z-Score | 1.53 |
Piotroski F-Score | 4.00 |
Positive ROA | N |
Positive CFROA | N |
Higher ROA y-y | N |
Cash flow > Earnings | Y |
Lower Leverage y-y | Y |
Higher Current Ratio y-y | N |
Less Shares Outstanding y-y | N |
Gross Margin Increase y-y | Y |
Higher Asset Turnover y-y | Y |
DCPH Number of Guru Trades
DCPH Volume of Guru Trades
Gurus Latest Trades with NAS:DCPH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:DCPH is held by these investors
Total 2
Deciphera Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:DCPH
Total 0- 1